Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Celsius Holdings Acquires Alani Nu for $1.8 Billion

Celsius Holdings, Inc. has successfully completed the acquisition of Alani Nutrition LLC (Alani Nu) for $1.8 billion, including $150 million in tax assets, resulting in a net purchase price of $1.65 billion, which was paid in a combination of cash and stock. This acquisition is expected to position Celsius Holdings as a leading player in the functional beverage market, catering to the increasing consumer preference for healthier, zero-sugar beverage alternatives.

The acquisition aims to reach a larger consumer base seeking better-for-you, functional beverages as a healthier substitute for traditional sugary energy drinks. The combination of Celsius and Alani Nu is anticipated to capitalize on the growing demand for such products.

Max Clemons, co-founder of Alani Nu, expressed confidence in the brand's potential for growth within the Celsius family, emphasizing the strong brand and differentiated consumer base that Alani Nu has built.

The key leadership team members of Alani Nu's prior owners have agreed to continue as advisors to Celsius, contributing to the ongoing business momentum and ensuring the seamless integration of Alani Nu within the Celsius Holdings portfolio.

Celsius Holdings, Inc. (NASDAQ: CELH) is a functional beverage company that owns the energy drink brand Celsius®, the hydration brand Celsius Hydration™, and the health and wellness brand Alani Nu®. The company is recognized for its leading functional beverage products, targeting the rapidly growing, better-for-you, functional beverage category. As a result of these announcements, the company's shares have moved 0.5% on the market, and are now trading at a price of $35.81. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS